Sippican Capital Advisors Merck & Co., Inc. Transaction History

Sippican Capital Advisors

  • $130 Million
  • Q3 2024

A detailed history of Sippican Capital Advisors transactions in Merck & Co., Inc. stock. As of the latest transaction made, Sippican Capital Advisors holds 20,668 shares of MRK stock, worth $2.13 Million. This represents 1.8% of its overall portfolio holdings.

Number of Shares
20,668
Previous 20,678 0.05%
Holding current value
$2.13 Million
Previous $2.56 Million 8.28%
% of portfolio
1.8%
Previous 2.19%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024
SELL
$111.15 - $128.97 $1,111 - $1,289
-10 Reduced 0.05%
20,668 $2.35 Million
Q2 2024

Aug 06, 2024
SELL
$123.8 - $132.96 $371 - $398
-3 Reduced 0.01%
20,678 $2.56 Million
Q1 2024

May 02, 2024
SELL
$113.24 - $131.95 $258,640 - $301,373
-2,284 Reduced 9.95%
20,681 $2.73 Million
Q4 2023

Jan 30, 2024
BUY
$100.18 - $109.02 $173,511 - $188,822
1,732 Added 8.16%
22,965 $2.5 Million
Q3 2023

Oct 24, 2023
BUY
$102.95 - $114.33 $30,885 - $34,299
300 Added 1.43%
21,233 $2.19 Million
Q2 2023

Aug 15, 2023
SELL
$108.61 - $118.38 $65,491 - $71,383
-603 Reduced 2.8%
20,933 $2.42 Million
Q1 2023

Jul 14, 2023
SELL
$102.94 - $114.86 $195,791 - $218,463
-1,902 Reduced 8.12%
21,536 $2.29 Million
Q4 2022

Jan 26, 2023
SELL
$87.44 - $112.11 $55,174 - $70,741
-631 Reduced 2.62%
23,438 $0
Q3 2022

Oct 17, 2022
SELL
$84.53 - $94.96 $68,891 - $77,392
-815 Reduced 3.28%
24,069 $2.07 Million
Q2 2022

Jul 19, 2022
SELL
$83.49 - $94.64 $11,688 - $13,249
-140 Reduced 0.56%
24,884 $2.27 Million
Q1 2022

Apr 20, 2022
BUY
$73.51 - $82.4 $42,341 - $47,462
576 Added 2.36%
25,024 $2.05 Million
Q4 2021

Jan 19, 2022
BUY
$72.28 - $90.54 $47,777 - $59,846
661 Added 2.78%
24,448 $1.87 Million
Q3 2021

Oct 20, 2021
BUY
$71.68 - $78.83 $101,785 - $111,938
1,420 Added 6.35%
23,787 $1.79 Million
Q2 2021

Jul 22, 2021
BUY
$70.31 - $77.77 $135,346 - $149,707
1,925 Added 9.42%
22,367 $1.74 Million
Q1 2021

Apr 15, 2021
BUY
$68.86 - $81.11 $146,602 - $172,683
2,129 Added 11.63%
20,442 $1.58 Million
Q4 2020

Jan 21, 2021
SELL
$71.77 - $79.65 $174,903 - $194,107
-2,437 Reduced 11.74%
18,313 $1.5 Million
Q3 2020

Oct 23, 2020
BUY
$73.18 - $82.95 $1.52 Million - $1.72 Million
20,750 New
20,750 $1.72 Million
Q2 2020

Jul 15, 2020
SELL
$70.42 - $80.13 $68,166 - $77,565
-968 Reduced 4.73%
19,498 $1.51 Million
Q1 2020

Apr 16, 2020
SELL
$63.36 - $87.82 $77,045 - $106,789
-1,216 Reduced 5.61%
20,466 $1.58 Million
Q4 2019

Jan 21, 2020
BUY
$77.58 - $87.54 $3,335 - $3,764
43 Added 0.2%
21,682 $1.97 Million
Q3 2019

Oct 17, 2019
SELL
$76.08 - $82.93 $76,384 - $83,261
-1,004 Reduced 4.43%
21,639 $1.82 Million
Q2 2019

Jul 17, 2019
SELL
$69.84 - $81.59 $203,164 - $237,345
-2,909 Reduced 11.38%
22,643 $1.9 Million
Q1 2019

Apr 17, 2019
SELL
$69.58 - $79.36 $208,740 - $238,080
-3,000 Reduced 10.51%
25,552 $2.13 Million
Q4 2018

Jan 16, 2019
BUY
$65.24 - $75.71 $20,811 - $24,151
319 Added 1.13%
28,552 $2.18 Million
Q3 2018

Nov 13, 2018
SELL
$57.69 - $67.84 $1.75 Million - $2.06 Million
-30,417 Closed
0 $0
Q2 2018

Jul 17, 2018
SELL
$50.83 - $59.72 $3,761 - $4,419
-74 Reduced 0.24%
30,417 $1.85 Million
Q1 2018

Apr 24, 2018
BUY
$50.96 - $59.23 $119,042 - $138,361
2,336 Added 8.3%
30,491 $1.66 Million
Q4 2017

Jan 17, 2018
BUY
$51.62 - $61.64 $452,294 - $540,089
8,762 Added 45.18%
28,155 $1.58 Million
Q3 2017

Oct 30, 2017
BUY
$58.67 - $63.13 $1.14 Million - $1.22 Million
19,393
19,393 $1.24 Million

Others Institutions Holding MRK

# of Institutions
3,824
Shares Held
1.88B
Call Options Held
15.6M
Put Options Held
13.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $261B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Sippican Capital Advisors Portfolio

Follow Sippican Capital Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sippican Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Sippican Capital Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email